ABPO (Abpro Holdings) Moat Score: 2/10 (As of Jun. 27, 2026)


ABPO Abpro Holdings Inc ABPO
9 GF Score
Price $0.22
! 1 Warning Sign
View Full Analysis

What is Abpro Holdings Moat Score?

Abpro Holdings ABPO +3.66% 9 Moat Score is 2 as of Jun. 27, 2026. GuruFocus rates ABPO with a GF Score™ of 9/100. The stock has 1 warning sign investors should review. Among 1,404 Biotechnology companies, Abpro Holdings ranks better than 58.12% on this metric.

Abpro Holdings has the Moat Score of 2, which implies that the company might have No Moat - Very weak/transient advantages.

Abpro Holdings has No Moat: Abpro Holdings operates in a competitive biotech sector with minimal differentiation. It lacks strong intellectual property, brand strength, or cost advantages, resulting in a weak competitive position.

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes Abpro Holdings might have No Moat - Very weak/transient advantages.

Abpro Holdings  (OTCPK:ABPO) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

Abpro Holdings Moat Score Related Terms

ABPO vs LYRA, ATXI, PTIX: Moat Score Comparison

For the Biotechnology subindustry, Abpro Holdings's Moat Score, along with its competitors' market caps and Moat Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Abpro Holdings Moat Score vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Abpro Holdings's Moat Score distribution charts can be found below:

* The bar in red indicates where Abpro Holdings's Moat Score falls into.


ABPO
9GF Score
Abpro Holdings Inc ABPO
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Moat Score →
What does a Moat Score of 2 mean?
Abpro Holdings (ABPO) has a Moat Score of 2 as of Jun. 27, 2026. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. According to the industry distribution chart, Abpro Holdings ranks #588 out of 1404 companies in the Biotechnology industry, placing it in the top 41.9%.
Is Abpro Holdings' Moat Score too high?
Abpro Holdings' current Moat Score is 2. The Biotechnology industry median Moat Score is 2.00. Abpro Holdings' value of 2 is 0% at this industry median. Based on the distribution chart, Abpro Holdings ranks #588 out of 1404 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Abpro Holdings has a GF Score™ of 9/100, reflecting its overall financial health beyond just this single metric.
How does Abpro Holdings' Moat Score compare to LYRA and ATXI?
According to the Biotechnology industry distribution chart, Abpro Holdings ranks #588 out of 1404 companies for Moat Score. This puts Abpro Holdings in the upper half of its industry. The industry median Moat Score is 2.00. Abpro Holdings' value of 2 is 0% at this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Moat Score for a Biotechnology company?
The median Moat Score among Biotechnology companies is 2.00, based on 1,404 companies in the industry. Companies in the top quartile (top 25%) have a Moat Score significantly above this median, while those in the bottom quartile fall well below. However, Moat Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Abpro Holdings's current Moat Score of 2 is 0% at the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Moat Score mean?
A high Moat Score can signal that a stock is expensive relative to its fundamentals. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. For the Biotechnology industry, the median Moat Score is 2.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Abpro Holdings's current Moat Score is 2. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Abpro Holdings stock overvalued right now?
Abpro Holdings (ABPO) has a current Moat Score of 2. The current Moat Score is 2 and 0% at the Biotechnology industry median of 2.00. Abpro Holdings' overall GF Score™ is 9/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Moat Score calculated?
Moat Score is calculated from a company's financial statements. For Abpro Holdings (ABPO), the current Moat Score is 2 as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Abpro Holdings Business Description

Address 100 Summit Drive, Burlington, MA, USA, 01803
Abpro Holdings Inc is a biotechnology company dedicated to developing next-generation antibody therapeutics with the goal of improving the lives of patients with severe and life-threatening diseases. The company is focused on novel antibody constructs for immuno-oncology, ophthalmology, and infectious diseases. By leveraging its proprietary DiversImmune and MultiMabTM antibody discovery and engineering platforms, the company is developing a pipeline of next-generation antibodies, both independently and through collaborations with pharmaceutical and research institutions.
9GF Score

Get the complete analysis for ABPO

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.22
Price